EN DE

Omega Healthcare Investors Inc (OHI) Fair Value & Analysis

Real Estate · US · Market cap $15.3B · ISIN US6819361006

What is Omega Healthcare Investors Inc really worth?

OH Omega Healthcare Investors Inc logo Omega Healthcare Investors Inc OHI · US
Price$47.04
Fair Value$24.81
Upside−47.3%
Quality44/100

Below-average quality, and trading another 90% above our fair value of $24.81.

Watch Omega Healthcare Investors Inc for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free

Strengths

Highly profitable · 68.1% net margin
Moderate debt · generates free cash flow
Wide moat 71/100

Risks

!Expensive Growth (revenue 5y +6.1 %/yr)
!Mixed vs. peers (6/15)

For context

·5.70% dividend yield
Evidence: High Range $18.61 – $31.02

Fair value as of: Sep 1, 2026

From 15 valuation models · updated 4 days ago

Share price −3.5% over the past month.

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

What matters now

  • The price sits above even our optimistic bull case ($31.02). The favourable scenario is already priced in.
  • Weak quality (44/100) and above fair value at the same time, the margin of safety is missing on both counts.
  • As a real-estate business, asset- and dividend-based methods carry more weight here than a standard DCF.

Price vs Fair Value (5 years)

$51.03 $18.21 Fair Value $24.81 Jun 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 1, 2026.

How to read this chart

60‑month range $18.21 – $51.03 · fair‑value band $18.61 – $31.02 · the $47.04 price screens above the $24.81 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 1, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Omega Healthcare Investors Inc (OHI) currently trades at $47.04, while our model-based Fair Value estimate is $24.81, implying the stock looks roughly 89.6% overvalued today. The Quality Score stands at 44/100 (below-average quality), in the Real Estate sector. Bull case: the DCF Models group reads highest at a median of $55.15 per share, and 5 of the 15 models we run sit above the $47.04 price. Bear case: the Asset-Based group reads lowest at $11.61, and 10 of the 15 models stay below the price. Evidence for this calculation is high.

Over the trailing twelve months, Omega Healthcare Investors Inc generated revenue of $1.2B at a net margin of 51.4%. Revenue grew 14.3% year over year. It earns a return on equity of 12.6%. Net debt stands at $4.2B. Fundamentals as of Sep 1, 2026

Our scenario range runs from $18.61 (bear case) to $31.02 (bull case); at $47.04, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 5% below its 52-week high and 40% above its 52-week low, currently above its 200-day average. For context, the median of 10 Real Estate peers we cover trades at −49% fair-value upside, at −47%, OHI screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted, family-balanced blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small. Every input is real reported data, nothing guessed.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
FCF DCF $23.92 $55.15 $109.75 75
Residual Income $15.90 $18.10 $28.22 75
Growth DCF $23.60 $52.19 $100.79 74
All 15 models by family
DCF Models
FCF DCF $23.92 $55.15 $109.75 75
5Y Revenue Exit $11.24 $27.68 $49.55 69
5Y EBITDA Exit $26.82 $59.90 $101.55 72
10Y Revenue Exit $14.51 $31.60 $57.04 63
10Y EBITDA Exit $25.53 $55.26 $100.73 65
Dividend Discount
Gordon GGM $23.96 $49.81 $79.02 66
DDM Multi-Stage $23.96 $42.00 $52.28 66
Multiples
P/S Multiple $19.53 $26.04 $32.54 58
P/B Multiple $25.15 $33.54 $41.92 55
EV/EBIT $27.20 $40.98 $54.76 65
EV/EBITDA $31.67 $46.94 $62.21 66
EV/Revenue $5.49 $13.90 $22.31 50
Asset-Based
NCAV (Graham) $8.66 $11.61 $17.32 54
Growth DCF
Growth DCF $23.60 $52.19 $100.79 74
Economic Profit
Residual Income $15.90 $18.10 $28.22 75

Widest divergence: DCF Models ($55.15) versus Asset-Based ($11.61). Highest evidence: FCF DCF (75).

Notify me when OHI reaches fair value

Put OHI on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Free, no payment details. Unsubscribe anytime in one click.

Key figures & financial health

P/E ratio 17.2 as of Aug 11, 2026
P/S ratio 8.49 P/E × margin
EPS (TTM) $2.81 price ÷ EPS = P/E 17.2
Dividend yield 5.7% payout 95.4%
Net margin 49.3% FY2025
Return on equity 16.5% TTM
More key figures
Profitability
Return on assets (EBIT) 5.9% avg 5y
Operating margin 61.5% TTM
Growth
Revenue (TTM) $1.3B TTM
Revenue growth (YoY) +11.2% 3y avg +10.9%
EPS growth (YoY) +161%
Balance sheet & cash flow
Free cash flow $879M FY2025
Net debt $4.2B FY2025 · ≈ 4.8 yrs of FCF

Figures from reported company fundamentals · as of Sep 1, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 44/100

Of which business quality 43 · Market factors (momentum, volatility) 66

Profitability 41
Margins and returns on capital today
Quality Growth 58
Are margins and returns improving?
Cashflow 67
Earnings quality: real cash, not paper profit
Fin. Strength 39
Balance sheet, leverage, solvency risk
Investment 45
Disciplined investing over empire-building
Low Volatility 90
Calm price path (market factor)
Momentum 53
Price trend over the last 3–12 months (market factor)
52W Momentum 61
Distance to the 52-week high (market factor)
Net Issuance 0
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

All values are scores from 0 to 100 (100 = best against fixed, research-based bands), not percentages. The three market factors (momentum, 52-week proximity, low volatility) are displayed but carry zero weight in the headline number: market sentiment is not a business property.

About the company

Omega Healthcare Investors, Inc. is a Real Estate Investment Trust. The firm is providing financing and capital to the long-term healthcare industry in the United States and the United Kingdom with a focus on skilled nursing and assisted living facilities, including care homes in the United Kingdom.

Full company description

Omega Healthcare Investors, Inc. is a Real Estate Investment Trust. The firm is providing financing and capital to the long-term healthcare industry in the United States and the United Kingdom with a focus on skilled nursing and assisted living facilities, including care homes in the United Kingdom. As of September 30, 2025, Omega has a portfolio of investments that includes 1,024 operating facilities located in 42 states, the District of Columbia and the United Kingdom/Jersey (290 facilities) and operated by 88 different operators. Additionally, Omega has investments in several unconsolidated entities that own 19 facilities. As a source of capital to the healthcare industry, Omega continually evaluates the opportunities, trends and challenges affecting the industry. Our goal is to identify long-term investments in quality healthcare properties with outstanding operators that provide the most favorable risk/reward ratio to our investors. Omega Healthcare Investors, Inc. is based in Hunt Valley, United States.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Omega Healthcare Investors Inc reported revenue of $1.2B in FY2025 versus $1.1B in FY2021, a compound +3.0%/yr. Reported net income was $590M in FY2025, compounding +9.1%/yr from FY2021.

Growth Quality 62/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Latest Revenue (FY 2025)
$1.2B
Latest YoY
+14.0%
Avg. revenue growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+10.9%
Avg. revenue growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+6.1%
Avg. revenue growth/yr (33Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+17.5%
Value creation/yr (5Y) Earnings growth per share (CAGR 5 years) plus dividend yield: value created per share and year.
+10.0% (4.3 + 5.7)
Revenue +3.0%/yr
FY21 $1.1B
FY22 $878M
FY23 $950M
FY24 $1.1B
FY25 $1.2B
Net income +9.1%/yr
FY21 $417M
FY22 $427M
FY23 $242M
FY24 $406M
FY25 $590M
Character of growth · EPS growth decomposed (2014-2025) −0.8 % p.a.
Revenue per share −1.0 %

of which total revenue +4.5 % · buybacks/dilution −5.3 %

EBIT margin −0.4 %
Tax rate +1.4 %
Residual (interest, one-offs) −0.7 %

Annual growth per factor. These are factors, not summands: multiplied they give the EPS growth rate, added they do not quite. Start and end points are 3-year averages (details on hover).

OHI screens 90% overvalued. Compare with Welltower Inc →

Share or link this analysis
𝕏 Post WhatsApp LinkedIn Reddit
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Omega Healthcare Investors Inc Fair Value". https://www.fairvalue-calculator.com/stock/OHI

Recent news

External third-party headlines (Yahoo Finance, Reuters and others), not an editorial selection.

Peer Group

REIT - Healthcare Facilities · 25 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 44 · Below median
Fair Value upside −47% · Below median
Return on equity (TTM) 17% · Top 25%
Return on assets 5% · Top 25%
Net margin (TTM) 68% · Top 25%
Operating margin (TTM) 61% · Above median
Revenue growth 11% · Above median
Dividend yield (TTM) 5.7% · Below median
Debt / equity 0.82× · Higher than median

Valuation Multiples vs REIT - Healthcare Facilities median · lower = cheaper

P/E (TTM) 17.2× · Cheaper than median
P/B 2.95× · Pricier than 75% of peers
P/S (TTM) 12.12× · Pricier than 75% of peers
P/FCF 17.4× · Pricier than median
EV/EBITDA 17.1× · Pricier than median
PEG 11.99× · Pricier than 75% of peers

Strength profile in five axes (Snowflake)

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE0 · sector 6
FUTURE56 · sector 36
PAST66 · sector 23
HEALTH59 · sector 73
DIVIDEND100 · sector 100

VALUE 0: the price sits above our fair-value range.

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more REIT - Healthcare Facilities stocks, each showing price versus our Fair Value estimate (as of Sep 1, 2026).

Stock Price Fair Value vs Fair Value
Welltower Inc WELL $238.07 $41.85 −82%
Ventas, Inc VTR $89.01 $17.91 −80%
Healthpeak Properties, Inc DOC $21.40 $6.95 −68%
American Healthcare REIT, Inc AHR $56.19 $10.94 −81%
CareTrust REIT, Inc CTRE $39.61 $22.79 −42%
Healthcare Realty Trust Incorporated HR $19.39 $20.60 +6%
Aedifica NV AED €66.55 €34.97 −47%
Chartwell Retirement Residences CSHUN C$21.17 C$3.49 −84%
Sabra Health Care REIT, Inc SBRA $20.39 $10.49 −49%
National Health Investors, Inc NHI $72.27 $64.82 −10%

Compare Omega Healthcare Investors Inc with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Real Estate stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screener Filter by region, size and sector Compare tool Two stocks side by side Extrinsic Value Calculator (Options) Splits an option premium into intrinsic and extrinsic (time) value. Peter Lynch Fair Value Formula & Calculator Apply Peter Lynch's fair value formula in seconds: fair P/E ≈ earnings growth (+ dividend) - free, with formula and example.

Frequently asked questions

Is Omega Healthcare Investors Inc (OHI) overvalued or undervalued?
As of Sep 1, 2026, our model estimates a fair value of $24.81 versus a price of $47.04, about −47% upside (overvalued).
What is the fair value of OHI?
Our model-based fair value for Omega Healthcare Investors Inc is $24.81 (as of Sep 1, 2026), built from audited fundamentals. The current price: $47.04.
What is the quality score of OHI?
Omega Healthcare Investors Inc has a Quality Score of 44/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Omega Healthcare Investors Inc (OHI)?
Omega Healthcare Investors Inc reported trailing-twelve-month revenue of about $1.2B (latest available figure, as of Sep 1, 2026).
What is the net profit margin of OHI?
The net profit margin of Omega Healthcare Investors Inc is about 51.4%, meaning it keeps roughly 51.4% of revenue as net income. Based on the latest reported figures.
Does Omega Healthcare Investors Inc pay a dividend?
Omega Healthcare Investors Inc currently shows a dividend yield of about 5.70% relative to its recent price (as of Sep 1, 2026).
Free · no account needed

Watch Omega Healthcare Investors Inc in the live analysis

One click puts Omega Healthcare Investors Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.